As of 2026-05-27, the Relative Valuation of Ryman Healthcare Ltd (RYM.NZ) is (8.50) NZD. This relative valuation is based on P/E multiples. With the latest stock price at 2.22 NZD, the upside of Ryman Healthcare Ltd based on Relative Valuation is -482.8%.
The range of the Relative Valuation is (7.76) - (8.49) NZD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 17.4x | 16.3x |
| Forward P/E multiples | 12.9x - 15.0x | 13.6x |
| Fair Price | (7.76) - (8.49) | (8.50) |
| Upside | -449.7% - -482.4% | -482.8% |
| Date | P/E |
| 2026-05-26 | -3.91 |
| 2026-05-25 | -3.86 |
| 2026-05-22 | -3.84 |
| 2026-05-21 | -3.61 |
| 2026-05-20 | -3.51 |
| 2026-05-19 | -3.58 |
| 2026-05-18 | -3.52 |
| 2026-05-15 | -3.75 |
| 2026-05-14 | -3.77 |
| 2026-05-13 | -3.88 |
| 2026-05-12 | -3.93 |
| 2026-05-11 | -3.88 |
| 2026-05-08 | -3.93 |
| 2026-05-07 | -3.97 |
| 2026-05-06 | -3.97 |
| 2026-05-05 | -3.82 |
| 2026-05-04 | -3.91 |
| 2026-05-01 | -3.82 |
| 2026-04-30 | -3.74 |
| 2026-04-29 | -3.74 |
| 2026-04-28 | -3.82 |
| 2026-04-24 | -4.02 |
| 2026-04-23 | -3.88 |
| 2026-04-22 | -3.70 |
| 2026-04-21 | -3.68 |
| 2026-04-20 | -3.54 |
| 2026-04-17 | -3.52 |
| 2026-04-16 | -3.67 |
| 2026-04-15 | -3.77 |
| 2026-04-14 | -3.65 |
| 2026-04-13 | -3.58 |
| 2026-04-10 | -3.67 |
| 2026-04-09 | -3.75 |
| 2026-04-08 | -3.84 |
| 2026-04-07 | -3.77 |
| 2026-04-02 | -3.77 |
| 2026-04-01 | -3.65 |
| 2026-03-31 | -3.74 |
| 2026-03-30 | -3.61 |
| 2026-03-27 | -3.75 |
| 2026-03-26 | -3.81 |
| 2026-03-25 | -3.81 |
| 2026-03-24 | -3.72 |
| 2026-03-23 | -3.77 |
| 2026-03-20 | -3.97 |
| 2026-03-19 | -3.91 |
| 2026-03-18 | -3.98 |
| 2026-03-17 | -3.98 |
| 2026-03-16 | -4.07 |
| 2026-03-13 | -4.05 |